Horizon Therapeutics Plc Other Current Liabilities

Horizon Therapeutics Plc (HZNP) currently reports a other current liabilities of $820M as of June 2023. That compares with $760M in the prior-year period — up 7.9% year over year. Use the charts on this page to explore Horizon Therapeutics Plc's other current liabilities history and peer comparisons.

Horizon Therapeutics Plc's other current liabilities increased from $760M to $820M — a 7.9% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Horizon Therapeutics Plc reported $820M in other current liabilities as of June 2023. That compares with $760M in the prior-year period — up 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $820M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Horizon Therapeutics Plc, and consider following HZNP for alerts when major investors trade the stock.

Horizon Therapeutics Plc is classified in the Healthcare sector. On other current liabilities, it currently shows $820M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HZNP with unrelated industries.